These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12873992)

  • 1. Increased plasma DNA integrity in cancer patients.
    Wang BG; Huang HY; Chen YC; Bristow RE; Kassauei K; Cheng CC; Roden R; Sokoll LJ; Chan DW; Shih IeM
    Cancer Res; 2003 Jul; 63(14):3966-8. PubMed ID: 12873992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
    Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
    J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA integrity in plasma and serum of patients with malignant and benign diseases.
    Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
    Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA integrity assay: a plasma-based screening tool for the detection of prostate cancer.
    Hanley R; Rieger-Christ KM; Canes D; Emara NR; Shuber AP; Boynton KA; Libertino JA; Summerhayes IC
    Clin Cancer Res; 2006 Aug; 12(15):4569-74. PubMed ID: 16899603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
    Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
    Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
    Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
    J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.
    Altimari A; Grigioni AD; Benedettini E; Gabusi E; Schiavina R; Martinelli A; Morselli-Labate AM; Martorana G; Grigioni WF; Fiorentino M
    Am J Clin Pathol; 2008 May; 129(5):756-62. PubMed ID: 18426736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of plasma cell-free DNA in patients with gastric cancer.
    Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
    Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients.
    Chan KC; Leung SF; Yeung SW; Chan AT; Lo YM
    Clin Cancer Res; 2008 Jul; 14(13):4141-5. PubMed ID: 18593992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
    Kamel AM; Teama S; Fawzy A; El Deftar M
    Tumour Biol; 2016 Jun; 37(6):7565-72. PubMed ID: 26684805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G is a potential tumor marker in malignant ascites.
    Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
    Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C; Hu L; Xia L; Li Y
    Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
    Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
    J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free DNA concentration and integrity as a screening tool for cancer.
    Zaher ER; Anwar MM; Kohail HM; El-Zoghby SM; Abo-El-Eneen MS
    Indian J Cancer; 2013; 50(3):175-83. PubMed ID: 24061455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.
    Huang ZH; Li LH; Hua D
    Cancer Lett; 2006 Nov; 243(1):64-70. PubMed ID: 16412565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer.
    Deligezer U; Eralp Y; Akisik EZ; Akisik EE; Saip P; Topuz E; Dalay N
    Ann N Y Acad Sci; 2008 Aug; 1137():175-9. PubMed ID: 18837944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
    Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
    BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.
    Flamini E; Mercatali L; Nanni O; Calistri D; Nunziatini R; Zoli W; Rosetti P; Gardini N; Lattuneddu A; Verdecchia GM; Amadori D
    Clin Cancer Res; 2006 Dec; 12(23):6985-8. PubMed ID: 17145818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.